window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-K89K5GY17G');
14 11, 2022

BD and Decode Health: Innovating to bring molecular tests to patients’ homes

2022-11-15T12:27:31-06:00

We’re excited to announce the BD and Decode Health strategic partnership that will accelerate innovation and advance precision medicine. Together, we’re working to advance at home collections for molecular biomarkers like RNA using a simple finger stick. Our work could unlock groundbreaking innovations for biomarker discovery and routine screening across multiple disciplines from oncology to autoimmune diseases and beyond. At-home testing can significantly improve efficiency and enhance diversity in clinical trials, speeding the development of potentially life-saving treatments.

BD and Decode Health: Innovating to bring molecular tests to patients’ homes2022-11-15T12:27:31-06:00
18 10, 2022

Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development

2022-10-18T08:35:06-06:00

Decode Health, a healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, today announced a new phase of its collaboration with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to empower drug and diagnostics research and development in the growing fields of metabolic disease and autoimmune neurology.

Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development2022-10-18T08:35:06-06:00
30 08, 2022

Biomarker Discovery to Improve Clinical Trials and Advance Precision Medicine

2022-09-27T12:07:00-06:00

In the U.S., the cost of chronic diseases is more than $3.7T1 annually. Massive amounts of healthcare data are generated through wearable data, healthcare claims, electronic health records, and even complex genomic datasets. By 2025, the average individual will accumulate more than 4,900 daily digital device interactions2. Data alone, however, isn't the answer. The key is to find patterns within the data to proactively intervene and reduce the inefficiency within the $808 billion3 healthcare industry.

Biomarker Discovery to Improve Clinical Trials and Advance Precision Medicine2022-09-27T12:07:00-06:00
27 05, 2021

Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics

2022-09-27T13:06:44-06:00

According to an article in the Journal of the American Medical Association (JAMA), two Harvard economists estimate the cumulative financial costs of the COVID-19 pandemic at more than $16 trillion. To put this number into perspective, that’s approximately 90% of annual GDP of the United States or $200,000 for a family of four. This is a combination of lost income due to the COVID-induced recession and the economic effect of a shorter, less healthy life.

Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics2022-09-27T13:06:44-06:00
7 12, 2020

Addressing the Emergent Issue of Long COVID

2022-09-27T13:10:21-06:00

Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some COVID patients are reporting a wide variety of debilitating symptoms, often lasting months after being diagnosed. [read more...]

Addressing the Emergent Issue of Long COVID2022-09-27T13:10:21-06:00
11 11, 2020

Decode Health Expands Strategic Advisory Board

2020-11-13T09:09:29-06:00

New members bring cross-industry insights to the company Nashville, Tenn. – Nov. 11, 2020 – Chase Spurlock, PhD, founder and CEO of Decode Health, announced the addition of two members to the company's Strategic Advisory Board. [read more...]

Decode Health Expands Strategic Advisory Board2020-11-13T09:09:29-06:00
31 07, 2020

Local Startup Develops AI Platform for Predicting COVID-19 Trends

2021-09-02T06:49:14-06:00

One-year-old technology startup Decode Health has developed a predictive artificial intelligence platform that identifies emerging trends in the COVID-19 outbreak, providing governments and other organizations early insights to where resources need to be allocated to provide targeted outreach among high-risk populations.

Local Startup Develops AI Platform for Predicting COVID-19 Trends2021-09-02T06:49:14-06:00
Go to Top